Blood and blood components (including haematopoietic progenitor cells ), are regulated under the Therapeutic Goods Act 1989 as medicines. Plasma-derived medical products are regulated as prescription medicines.
- Regulation of blood
Blood and blood components are regulated under the Therapeutic Goods Act 1989 - Autologous platelet-rich plasma and conditioned serum regulation
What they are and how they are regulated - Autologous human cells and tissues products regulation
How we apply regulation, based on the risk associated with the product, and when exclusions and exemptions apply - Forms for the blood and blood components industry
Links to forms for the blood and blood components industry
Contact details for blood and blood components
If your enquiry is not about blood or blood components, see: Contact the TGA
Email: bloodandtissues@tga.gov.au
Phone:
- 1800 678 799 (freecall within Australia)
- +61 2 6232 8443
Users who are deaf or have a hearing or speech impairment can call through the National Relay Service:
- TTY or computer with modem users: phone 1800 555 677 then ask for 1800 678 799
- Speak and listen (speech to speech relay) users: phone 1800 555 727 then ask for 1800 678 799
Fax: +61 2 6232 8939
Post: Scientific Evaluation Branch, Therapeutic Goods Administration, PO Box 100, Woden ACT 2606, Australia
Street address (for deliveries): Therapeutic Goods Administration, 27 Scherger Drive, Fairbairn ACT 2609, Australia
Topics